Milestones
2022.09 — PM1009: IND approval for FIH phase I study
PM1009: IND approval for FIH phase I study
2022.04 — PM1021: IND filing for phase I study in Australia
PM1021: IND filing for phase I study in Australia
2022.03 — PM1032 & PM1015: IND approval for FIH Phase I studies
PM1032 & PM1015: IND approval for FIH Phase I studies
2022.02 — PM8002: entered clinical phase II studies
PM8002: entered clinical phase II studies
2022.01 — PM1022: IND approval for FIH phase I study
PM1022: IND approval for FIH phase I study
2021.12 — PM8001: obtained FDA approval for global multi-center phase II clinical trial
PM8001: obtained FDA approval for global multi-center phase II clinical trial
2021.09 — PM1003: IND approval for FIH phase I study
PM1003: IND approval for FIH phase I study
2021.07 — PM8003: IND approval for FIH phase I study
PM8003: IND approval for FIH phase I study
2021.04 — PM8001: entered clinical phase IIa studies
PM8001: entered clinical phase IIa studies
2021.03 — Round B financing; PM8002: the first subject was enrolled
Round B financing; PM8002: the first subject was enrolled
2020.12 — Biotheus (Nantong) establishment
Biotheus (Nantong) establishment
2020.11 — Biotheus core team awarded as "Zhuhai City Innovation and Entrepreneurship Team"
Biotheus core team awarded as "Zhuhai City Innovation and Entrepreneurship Team"
2020.10 — PM8002: IND approval for FIH phase I study
PM8002: IND approval for FIH phase I study
2020.06 — Round A financing
Round A financing
2020.03 — PM8001: IND approval for FIH phase I study
PM8001: IND approval for FIH phase I study
2020.01 — Strategic collaboration with TILT
Strategic collaboration with TILT
2019.08 — Strategic cooperation with Aligator
Strategic cooperation with Aligator
2019.07 — Strategic cooperation with Genebase
Strategic cooperation with Genebase
2019.03 — Round pre-A financing
Round pre-A financing
2018.08 — Cooperation with the Zhuhai High-tech Zone Government
Cooperation with the Zhuhai High-tech Zone Government